Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico.
about
Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other MycobacteriaIsoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosisTuberculosis recurrence and mortality after successful treatment: impact of drug resistanceThe infectiousness of tuberculosis patients coinfected with HIVStrategies for treating latent multiple-drug resistant tuberculosis: a decision analysisTransmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort StudyComparison of restriction fragment length polymorphism with the polymorphic guanine-cytosine-rich sequence and spoligotyping for differentiation of Mycobacterium tuberculosis isolates with five or fewer copies of IS6110.Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistanceComparison of the genetic convergence between mycobacterium strains by three RFLP-based methods in central province of IranLong term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting.The burden of drug-resistant tuberculosis and mechanisms for its control.How soon should patients with smear-positive tuberculosis be released from inpatient isolation?Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review.Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence settingReview: multidrug-resistant tuberculosis: public health challenges.Association of Pulmonary Tuberculosis and Diabetes in Mexico: Analysis of the National Tuberculosis Registry 2000-2012.Mycobacterium tuberculosis Complex Genotype Diversity and Drug Resistance Profiles in a Pediatric Population in Mexico.Gender differentials of pulmonary tuberculosis transmission and reactivation in an endemic area.Evaluation of a semi-automated reporter phage assay for susceptibility testing of Mycobacterium tuberculosis isolates in South AfricaRecurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil.rpoB Gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism.Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness.Tuberculosis-related deaths within a well-functioning DOTS control program.Changes in the geographical distribution of tuberculosis patients in Veracruz, Mexico, after reinforcement of a tuberculosis control programme.Tuberculosis drug resistance: a global threat.Virulence, immunopathology and transmissibility of selected strains of Mycobacterium tuberculosis in a murine model.Prevalence and clinical predictors of drug-resistant tuberculosis in three clinical settings in Calabar, Nigeria.Will tuberculosis become resistant to all antibiotics?
P2860
Q28389409-7C0E7B20-E325-40F5-B0A6-8127DD406827Q28468519-0436CF4D-E6D0-4899-BB78-A0624CD91A0BQ28469011-915207D6-2B90-4F58-B33D-51475681075EQ28469052-6B1F3854-CFDB-422D-B67A-316B429C7C47Q28473650-CA54DF5A-D7D4-4B34-AFDB-37244FA136A9Q28478920-3D955D18-B487-46A2-B0F8-006EFD749AEAQ28548584-8B386746-AFBB-47E0-B2E4-6501FC11363CQ33627372-FE0B1142-27D4-490D-ADFD-902B9C418EF1Q33935393-624A2873-8524-4937-AFBA-73F39F58C595Q34065765-F230C545-FDD3-4C17-999E-527750562D86Q34454109-A27AF908-91F1-4351-B500-5C61C97D6724Q34497340-95779CCD-E40F-454F-B0E7-DAEE1CDC65C6Q34615266-5F55EDEE-AD8A-4776-8A5A-523FB2AEDA77Q34973711-0FFB5FD6-5E36-43AF-ADE2-B972D7D3B7A3Q35164268-91ECBAA7-09EA-46C6-A31B-1C10E90F33FCQ35210479-B06C12EB-4F2E-457A-867E-C97BCFCD587BQ35631580-2E7BC8D9-C2DD-4536-A9FA-CE0984F27584Q35663649-B98E0CBD-8552-4592-8D16-A1E991E8BABBQ35910338-C6B21423-E188-438C-9F0E-CC1311743942Q36183964-A359069B-F52B-4EBB-9E53-9CDD2AE07811Q36917012-19DDA71D-5497-4604-BB6D-D7D577AF8341Q37015711-790DFC65-B9B7-4078-A44E-51BB34566FC4Q37075222-4596A726-5EFA-4737-B958-7E487F0B8791Q37120860-3BD6BBEE-6A87-497F-8F4A-45941B2DCC98Q37334487-D44E09E8-F598-456E-8705-8A0D75B815E0Q39712518-5001AA28-4963-4FD5-B56F-92B5320EBA9EQ46902663-313A3563-8907-4624-81C1-BFE8BB0C213FQ54495954-B960E6A9-CD21-4748-9923-46CF0DCA386AQ54747725-003CFBAD-E673-4E5F-926D-57CFCEAB5DA7Q55180954-F5D5AE5A-EF86-45E4-A06A-ADF9BCE5B2F0
P2860
Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Clinical consequences and tran ...... berculosis in southern Mexico.
@en
Clinical consequences and tran ...... berculosis in southern Mexico.
@nl
type
label
Clinical consequences and tran ...... berculosis in southern Mexico.
@en
Clinical consequences and tran ...... berculosis in southern Mexico.
@nl
prefLabel
Clinical consequences and tran ...... berculosis in southern Mexico.
@en
Clinical consequences and tran ...... berculosis in southern Mexico.
@nl
P2093
P1476
Clinical consequences and tran ...... berculosis in southern Mexico.
@en
P2093
Balandrano-Campos S
Ferreyra-Reyes L
García-García ML
Jiménez-Corona A
Jiménez-Corona ME
Juárez-Sandino L
Olivera-Díaz H
Palacios-Martínez M
Ponce de León A
Sifuentes-Osornio J
P304
P356
10.1001/ARCHINTE.160.5.630
P407
P577
2000-03-01T00:00:00Z